A scheme for detection of abnormality in molecular nano-networks is proposed. This is motivated by the fact that early diagnosis, classification and detection of diseases such as cancer play a crucial role in their successful treatment. The proposed nano-abnormality detection scheme (NADS) comprises of a two-tier network of sensor nano-machines (SNMs) in the first tier and a data gathering node (DGN) at the sink. The SNMs detect the presence of competitor cells as abnormality that is captured by variations in parameters of a nano-communications channel. In the second step, the SNMs transmit micro-scale messages over a noisy micro communications channel (MCC) to the DGN, where a decision is made upon fusing the received signals. The detection performance of each SNM is analyzed by setting up a Neyman-Pearson test. Next, taking into account the effect of the MCC, the overall performance of the proposed NADS is quantified in terms of probabilities of misdetection and false alarm. A design problem is formulated, when the optimized concentration of SNMs in a sample is obtained for a high probability of detection and a limited probability of false alarm.
Introduction
Cancer is the leading cause of death in economically developed countries and the second leading cause of death in developing countries [1] . In fact, more than 7.6 million people lose their lives each year in the world due to the various forms of cancer [2] . Despite the advances made by significant innovations in the technology in the past decade, successful treatment of cancer is still a distant goal in general. Accurate diagnosis, classification and early detection of cancer are vital in overcoming the disease [3] .
The abnormality detection (AD) process based on molecular diagnosis can be used as an effective method for early cancer detection. Systems in the molecular environment are to distinguish two molecules A and B [4] [5] . The decisions are made using a recognizer molecule a . For example, molecule a is an antigen and molecule A is a pathogen that is to be diagnosed by molecule a , while the molecule B which is similar to A, is normally found in the body. The design of optimized molecular recognizers is studied in the biochemical noisy environment using a Bayesian cost in [4] .
A diagnosis process based on protein identification and considering reaction between genes and antigens with magnetic nano-sensors is investigated in [6] [7] . This type of nano-sensors can detect a nano-scale message by generating a specific signal in micro-scale. In [8] , the detection of abnormalities is examined using biomarkers in the blood as a detection feature. To identify breast cancer based on a breath test, a proof-of-concept system has been developed using a tailor-made nano-scale artificial nose [9] .
In this paper, a nano-abnormality detection scheme (NADS) is proposed for the detection of nano-scale abnormality in a biomolecular environment using a two tier decision making process. The abnormality is due to the existence of competitor cells in the said environment. The NADS includes a set of SNMs for the detection of a nano-scale abnormality over a nano-communication channel (NCC) using an appropriately designed detection feature. Then, the SNMs communicate their observations over a noisy micro communication channel (MCC) to a data gathering node (DGN) using micro scale messages (MSMs).
Fusing the collected signals, the DGN makes a decision and may alarm an abnormality as necessary. The analysis of SNM performance over the NCC is set up as a Neyman-Pearson test, which quantifies the probabilities of false alarm and misdetection. Finally, incorporating the effect of MCC, the total detection performance of NADS at the DGN is analyzed. The presented analysis is then used to obtain the optimized concentration of SNMs in the sample tissue for a prescribed high probability of detecting the abnormality and a bounded false alarm probability.
Certain schemes for cancer detection at the nano-scale, may be cast into the proposed two-tier network model of the NADS. Nano-sized magnetic resonance imaging (MRI) contrast agents is used for intraoperative imaging in the context of neuro-oncological interventions [10] [11] . In this scheme, detection in NCC is done using, Gadolinium-based nano-particle [12] , Ironoxide-based nano-particles or multiplemode imaging contrast nano-agents [13] - [18] . Moreover, detection over the MCC is accomplished using a combination of MRI and biological targeting [19] or optical detection [11] [19] [20] . As another scheme, nano-scale field-effect bio-transistors can be considered, in which silicon nano-wires [21] [22] detect an abnormal target in the NCC due to the molecular binding on their surface. This in turn affects the conductance of nano-wires, which is reported over the MCC. 5 The outline of this paper is as follows. In Section II, the preliminaries and problem statement are presented. The hypothesis test at an SNM for AD in nano-scale is derived in Section III. In Section IV, communications over the MCC is studied. Section V presents the analysis of the NADS performance and the associated numerical results. Concluding remarks are made in Section VI.
Preliminaries and Problem Statement
In this section, the setup of AD system and the problem statement of NADS are described. The detection process includes two parts. In the first part, each SNM detects the detection feature in nano-scale and generates the MSM; in the second part, the DGN collects the transmitted MSMs. Fig. 1 shows the schematic structure of NADS. The molecular environment is modeled by the NCC. In the healthy setting, no abnormality (here competitor cell) exists in the molecular environment and vice versa.
The molecular competitor changes the rate of binding between the molecules and the nano-receptors on the SNM. This is reflected in the NCC model [23] [24] . The MSM is then generated by the SNM as it detects this variation. The DGN collects the MSMs over the noisy MCCs and decides and declares the presence or the absence of the abnormality. The MCC is considered an additive white Gaussian noise (AWGN) channel.
Below, we continue with a detailed description of the NCC model and the detection feature.
Nano-Communication Channel
The NCC characterizes chemical reactions in the molecular environment. We consider a set of SNMs, which act as molecular receivers, injected into the biological tissue for test. We assume that the existing molecules in the molecular environment react with the receptors on SNMs. The molecules are assumed to be propagated by a virtual transmitter nano-machine (VTNM) following a periodic square pulse propagation pattern, i.e., during time interval H t a molecular pulse is emitted with concentration () Table 1 summarizes the parameters affecting the NCC transition probabilities.
Detection Feature
The biochemical activities of competitor cells, e.g., cancer cells, affect the molecular environment and change its parameters [4] . We model this as an abnormality in the molecular environment, which is to be detected as early as possible. The competitor cells can be considered as competitor nano-machines (CNMs)
for the SNMs. The presence of CNM affects the transition probability of the NCC in (13) and (14) . For example, the CNM can react with transmitted molecules by the VTNM. This reduces the concentration of transmitted molecules ex L , and hence, changes the transition probability of the NCC. This variation in transition probability can be used for modeling of protein identification for early cancer detection in nanoscale [27] . Alternatively, the CNM may devitalize the receptors on the SNMs, change 1 k -and 1 k on the SNM by a biochemical reaction or vary the temperature of nano-receptors on SNMs.
For the NCC, with given parameters in Table 1 and a given size of sample tissue, the number of excitation pulses per unit time from VTNMs influences the probability of receiving a given molecular bit in the SNM nano-receptor. Hence, we consider the average number of molecular bits A received at the SNMs per unit 
NP , an abnormality or the existence of competitor cells is detected.
Problem Statement
Here, we consider a design problem to determine the minimum required concentration of SNMs, M, in the sample size of V for a reliable NADS. The SNMs in general could be expensive and/or are chemical compounds which could affect the molecular environment or cause side effects if used in vivo. This motivates us to use them in smallest amount as possible. A reliable NADS is interpreted as one which provides a sufficiently high probability of detection (alarm), when the abnormality exists and a sufficiently small probability of (false) alarm, when the abnormality in fact does not exist in the molecular environment.
Hence, the desired optimization problem is formulated as follows
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where D P and F P are the detection and the false alarm probabilities of NADS on detecting the abnormality in the molecular environment, respectively. Also, x <1 is a constant close to unity and g is a positive constant close to zero.
Hypothesis Test for AD in the NCC
In this section, a hypothesis test is formulated for the detection of competitor cells in the molecular environment. This test determines the functionality of SNMs in the nano-scale. We derive a threshold level for generating the MSM by the SNM, which alarms the existence of competitor cells. To this end, for a bounded false alarm probability, a closed-form expression is derived for the probability of each SNM to detect the presence of different types of competitor cells. The associated hypothesis test is defined as The progress of cancer is modeled with parameter k, which corresponds to a given value of parameter 1 ¹ k . For a healthy molecular environment, we have 1 k = . Hence, for a given value of k, we may consider
The next theorem presents the resulting decision threshold for the hypothesis test and the detection probability. 
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Proof. See Appendix D.
NADS Performance Assessment
In this Section, first performance analysis of NADS is done. Then this analytical results are evaluated numerically in Subsection B.
A. Analytical Performance Evaluation
In this Subsection, analytical expressions for probabilities of detection and false alarm of the NADS are derived. To this end, an equivalent channel is obtained between the VTNMs. and the DGN by cascading the Proof. The NADS is composed of a broadcast channel with a common message from the VTNM in the first tier followed by Gaussian multiple access channel and an OR fusion rule [29] in the second tier. Fig. 2 shows a schematic diagram of the NADS. Theorems 2 and Proposition 1 quantify the performance of the two tiers. The NADS performance may be computed by considering two cascaded equivalent channels as shown in Fig. 3 , which directly leads to (34) and (35).□ ( ) Fig. 3 . Equivalent channel model between VTNM and DGN.
In this case, the probability of misdetection for the proposed NADS is given by 1.
MD PP =-
Our extensive experiments reveal that for the overall performance of the NADS, the designed MCC detector in Proposition 1, leads to a lower bound for D P and a tight upper-bound for F P (in comparison to those of an optimal detector). In addition, for an MCC with reasonably small error probability, e.g., a high performance medical imaging system, the said bounds approach the optimum solution.
B. Numerical Results
In this subsection, numerical results are provided for evaluation of the NADS performance. The parameters of the experiment set up in different figures are presented in Table 2 . We start with studying the effect of the characteristics of the SNM, in terms of its observation time and false alarm performance, on the NADS performance. Next, we examine how different levels of abnormality in the molecular environment (NCC) reflect in the NADS performance. Finally, the effect of noise intensity in the second tier of NADS on the overall performance is investigated. is achieved. This performance result is valid for all values of n, since in (35) for the given parameters in Table 2 , MCC P is fixed and NCC P holds with equality in (55) and is hence independent of n.
The presented results may be used to solve the optimization problem of (16) The typical trade-off of false alarm and detection performance of SNM over the NCC is depicted in Fig. 8 (Fig. 6 ), as it directly influences the NADS false alarm performance F P (Fig. 7 ). (23), may be interpreted as a disease which has progressed more and hence altered the status of the molecular environment more significantly from a healthy setting. Nevertheless, the detection performance of the NADS is still bounded by the noisy setting of MCC as evident in the error floor of the curves in Fig.   10 . As expected and evident in Fig. 11 , F P increases with M, and remains the same as k changes. This is due to the fact that in (35), for the given parameters in 
Concluding remarks
A nano-scale abnormality detection scheme was proposed for the detection of competitor cells in a biomolecular nano-network. This is motivated by the early detection and classification of the diseases and their effective treatment. The proposed NADS is a two-tier network. The SNMs at the first tier act as receivers of an NCC modeling the molecular environment. The SNMs then communicate over a noisy channel to a DGN, which operates based on an OR fusion rule. The average number of received molecular bits A per unit time serves as a feature for detecting the abnormalities at the SNMs. The detection performance of each SNM was analyzed with Poisson observations. Next, quantifying the overall NADS detection performance, optimized concentration of SNMs was obtained for a desired level of NADS reliability.
At the current stage of research into detection of diseases at the nano-scale, there are still many interesting related research problems. Here, we list a few of them:
· In this paper, the detection feature is set based on mathematical modeling and certain valid approximations. Developing more precise models or obtaining the exact detection feature based on experimental measurements in the target tissue is an interesting research avenue.
· Medical imaging is one approach to detection over the MCC. Realistic modeling of MCC noise is an interesting issue for enhancing the NADS performance for abnormality detection in the biomolecular environment.
· We opted a layered approach to the design of the considered two-tiered NADS. Such an approach is appealing as it lends itself to solutions with reasonable complexity. Alternatively, one may seek an optimum design of detectors for each of the NADS tiers based on the end-to-end NADS performance and the desired design problem in (16) . can be expressed based on the notations in (13) and (14), e.g., { } 
Appendix B
The decision thresholds for NCC with Poisson observations are derived. The GLRT for hypothesis test of (17) , which is denoted by U as defined in (30) . At the DGN, the purpose is to minimize the probability of error for the hypothesis test in (68). As the uniform cost [31] is to be calculated, the likelihood ratio is obtained as (75) and (76) the desired results are obtained. Of course, this leads to a larger error probability in comparison to the case with the optimal detector. Our experiments reveal that this upper bound is tight when the signal to noise ratio in MCC is higher than a specified level of about 10 dB. □
